CLINICAL_TRIALS
trial_result
· 2014-03-19
Clinical Trial Update: Rituximab for Prevention of Chronic GVHD [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating rituximab for the prevention of chronic graft-versus-host disease has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Hematological Malignancies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-19